GC310 Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GC310 Injection, covering 2025-09-15 to 2025-09-15. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of GC310 Injection in Patients With Wilson's Disease (WD) [Phase 1, Phase 2]